Key Metrics of Glenmark Pharmaceuticals
Revenue₹8,440 Cr▼ 8.5% YoYFY 2025-26
EBITDA₹48.6 Cr▼ 98.0% YoY
Net profit−₹201 Cr▼ 112.5% YoY
Net worth₹24,150 Cr▼ 1.4% YoY
Competitors10identified
About Glenmark Pharmaceuticals
Part of Glenmark Pharmaceuticals.
Sectors
Company details
- Website
- glenmarkpharma.com
- Founded
- 1977
- Registered office
- B-2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mahalaxmi, Mumbai, In-mh, 400026
- Listed
- NSE: GLENMARK · ₹2,225.80
Operational Areas of Glenmark Pharmaceuticals
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Pharmaceuticals & Healthcare›Large Pharma Companies
Pharmaceuticals & Healthcare›State-wise Pharma Manufacturers
Company summary
Entity details
CINL24299MH1977PLC019982
LEI code335800WKECZXIIT9GK20
State codeMH
PIN code400026
Current legal nameGLENMARK PHARMACEUTICALS
Classification—
Listing statusListed (NSE: GLENMARK)
Registration no.019982
Company age49 years, 9 months
PAN—
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation01 Jan 1977
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code24299
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Premium
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 4 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 34 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit assessment · Manufacturing
Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26
Indicative long-term—
Indicative short-term—
Score—
LiquidityStretched
DirectionStable
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Information on file | 56% · missing: Capex / investment plans, Lender details, Auditor details, Recent rating review (last 15 months) |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Registered office and contact
Registered officeB-2 MAHALAXMI CHAMBERS, 22 BHULABHAI DESAI ROAD, MAHALAXMI, MUMBAI, IN-MH, 400026
GSTIN—
Email—
Websitehttp://www.glenmarkpharma.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Glenmark Pharmaceuticals
Competitors10identified
Locations2most in India
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
 Dr. Reddy's Laboratories |
Part of Dr. Reddy's Laboratories. | drreddys.com | 1984 | India |
 Aurobindo Pharma |
Part of Aurobindo Pharma. | aurobindo.com | 1986 | Hyderabad, India |
 Cipla |
Part of Cipla. | cipla.com | 1935 | Mumbai, India |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lupin.com | 1968 | India | |
| Part of Biocon. | biocon.com | 1978 | Bangalore, India | |
 ALKEM LABORATORIES LIMITED |
Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | alkemlabs.com | 1973 | Mumbai, Maharashtra, India |
 Torrent Pharmaceuticals |
Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | torrentpharma.com | 1959 | Ahmedabad, India |
 Thomas Cook India |
Part of Thomas Cook Group. | thomascook.in | 1978 | Mumbai, India |
 Divi's Laboratories |
Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | divislabs.com | 1990 | Hyderabad, India |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | ipcalabs.com | 1949 | Mumbai, India |
Similar companies
I
Ipca LaboratoriesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
C
CiplaPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Same location: Mumbai
P
Panacea BiotecPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
E
Emcure PharmaceuticalsPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
D
Dr. Reddy's LaboratoriesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale
L
Laurus LabsPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
M
Marksans Pharma LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
D
Divi's LaboratoriesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Glenmark Pharmaceuticals
Business activities and related parties
Branded generics and specialty
Filings
No filings on record yet.